|
August 7, 2019 Dear Fellow Stockholders: On behalf of the Board of Directors (the "Board") of SELLAS Life Sciences Group, Inc. (the "Company"), you are cordially invited to attend a Special Meeting of Stockholders to be held at 8:30 a.m., local time, on September 10, 2019, at 15 West 38 th Street, 4 th Fl., New York, New York 10018. At the Special Meeting, stockholders will consider and vote on (i) a proposal to adopt and approve an amendment to our Amended and Restated Certificate of Incorporation to effect a reverse stock split of our common stock, par value $0.0001 per share (the “common stock”) at a ratio of not less than 1-for-20 and not greater than 1-for-60, with the exact ratio and effective time of the reverse stock split to be determined by the Board (the “Reverse Stock Split”) at any time within one year of the date of the Special Meeting; (ii) the approval of the Company’s 2019 Equity Incentive Plan; and (iii) if necessary, the adjournment of the Special Meeting to solicit additional proxies in favor of the Reverse Stock Split proposal and the 2019 Equity Plan proposal. The proxy statement attached to this letter provides you with information regarding the above three proposals. Please read the entire proxy statement carefully. You may obtain additional information about the Company from documents we file with the Securities and Exchange Commission. It is important that your shares be represented and voted at the meeting. Please vote as soon as possible even if you plan to attend the Special Meeting. We appreciate your continued ownership of the Company shares and your support regarding this matter. Very truly yours, Angelos M. Stergiou, M.D., Sc.D. h.c. President and Chief Executive Officer |
|
| aus der Diskussion: | Sellas Life Sciences Group (ehemals Galena Biopharma) |
| Autor (Datum des Eintrages): | KHL911 (13.08.19 19:57:57) |
| Beitrag: | 2,594 von 2,935 (ID:61245348) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |